Horgan, D.; Ciliberto, G.; Conte, P.; Curigliano, G.; Seijo, L.; Montuenga, L.M.; Garassino, M.; Penault-Llorca, F.; Galli, F.; Ray-Coquard, I.;
et al. Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine. Cancers 2021, 13, 583.
https://doi.org/10.3390/cancers13030583
AMA Style
Horgan D, Ciliberto G, Conte P, Curigliano G, Seijo L, Montuenga LM, Garassino M, Penault-Llorca F, Galli F, Ray-Coquard I,
et al. Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine. Cancers. 2021; 13(3):583.
https://doi.org/10.3390/cancers13030583
Chicago/Turabian Style
Horgan, Denis, Gennaro Ciliberto, Pierfranco Conte, Giuseppe Curigliano, Luis Seijo, Luis M. Montuenga, Marina Garassino, Frederique Penault-Llorca, Fabrizia Galli, Isabelle Ray-Coquard,
and et al. 2021. "Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine" Cancers 13, no. 3: 583.
https://doi.org/10.3390/cancers13030583
APA Style
Horgan, D., Ciliberto, G., Conte, P., Curigliano, G., Seijo, L., Montuenga, L. M., Garassino, M., Penault-Llorca, F., Galli, F., Ray-Coquard, I., Querleu, D., Riegman, P., Kerr, K., Van Poppel, H., Bjartell, A., Codacci-Pisanelli, G., Koeva-Balabanova, J., Paradiso, A., Maravic, Z.,
... Capoluongo, E.
(2021). Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine. Cancers, 13(3), 583.
https://doi.org/10.3390/cancers13030583